---
figid: PMC9530335__fnut-09-934113-g001
figtitle: Gut microbiota–mitochondrial inter-talk in non-alcoholic fatty liver disease
organisms:
- Escherichia coli
- Pseudomonas aeruginosa
- Enterococcus faecalis
- Bacillus cereus
- Faecalibacterium prausnitzii
- Akkermansia muciniphila
- Phocaeicola vulgatus
- Streptococcus mitis
- Prevotella copri
- Roseburia intestinalis
- Parabacteroides distasonis
- Bacteroides uniformis
- Bilophila wadsworthia
- Ruminococcus bromii
- Roseburia inulinivorans
- Blautia obeum
- Barnesiella intestinihominis
- Porphyromonas endodontalis
- Bacteroides acidifaciens
- Campylobacter concisus
- Odoribacter splanchnicus
- Bacteroides stercoris
- Dorea longicatena
- Holdemanella biformis
- Enterocloster bolteae
- Bacteroides xylanisolvens
- Lachnospira eligens
- Veillonella atypica
- Mucispirillum schaedleri
- Victivallis vadensis
- Bacteroides caecimuris
- Clostridium celatum
- Lactobacillus kefiranofaciens ZW3
- Allisonella histaminiformans
- Prevotella sp. AM42-24
- Butyricimonas virosa
- gut metagenome
- human metagenome
- Oscillibacter sp. CAG241
- Prevotella sp. CAG520
- Roseburia sp. CAG182
- Firmicutes bacterium CAG95
- Firmicutes bacterium CAG110
- Oryza sativa
- Glycine max
- Candida dubliniensis
- Olea europaea
- Fagopyrum esculentum
- Chenopodium quinoa
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Gorilla gorilla gorilla
- Danio rerio
organisms_ner:
- Mus musculus
- Drosophila melanogaster
pmcid: PMC9530335
filename: fnut-09-934113-g001.jpg
figlink: /pmc/articles/PMC9530335/figure/F1/
number: F1
caption: Gut microbiota imbalance contributes to the development of NAFLD. High-fat
  diet or high-cholesterol diet may lead the nutrition imbalance and change the gut
  microbiota composition and its metabolites, such as SCFAs, bile acids, and TAMVA.
  Simultaneously, the intestinal permeability was enhanced, and microbiota and its
  metabolites reach the liver through the portal vein. This abnormal biology results
  in dysfunction of lipid metabolism, inflammation, and then NAFLD. The gut–brain–liver
  axis is also involved in NAFLD. Microbiota disorders promote the intestinal endocrine
  L cells to secrete GLP-1 to act on the vagus nerve to activate the gut–brain–liver
  nerve pathway and regulate the insulin sensitivity, glucose production, fatty acid
  oxidation. GABA, gamma-aminobutyric acid; DA, dopamine; NA, noradrenaline; SCFAs,
  short-chain fatty acids; TMAVA, N,N,N-trimethyl-5-aminovaleric acid; GLP-1, glucagon-like
  peptide-1.
papertitle: Gut microbiota–mitochondrial inter-talk in non-alcoholic fatty liver disease.
reftext: Qi Zhang, et al. Front Nutr. 2022;9:934113.
year: '2022'
doi: 10.3389/fnut.2022.934113
journal_title: Frontiers in Nutrition
journal_nlm_ta: Front Nutr
publisher_name: Frontiers Media S.A.
keywords: NAFLD | gut microbiota | mitochondria | metabolites | probiotics | prebiotics
automl_pathway: 0.9336288
figid_alias: PMC9530335__F1
figtype: Figure
redirect_from: /figures/PMC9530335__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9530335__fnut-09-934113-g001.html
  '@type': Dataset
  description: Gut microbiota imbalance contributes to the development of NAFLD. High-fat
    diet or high-cholesterol diet may lead the nutrition imbalance and change the
    gut microbiota composition and its metabolites, such as SCFAs, bile acids, and
    TAMVA. Simultaneously, the intestinal permeability was enhanced, and microbiota
    and its metabolites reach the liver through the portal vein. This abnormal biology
    results in dysfunction of lipid metabolism, inflammation, and then NAFLD. The
    gut–brain–liver axis is also involved in NAFLD. Microbiota disorders promote the
    intestinal endocrine L cells to secrete GLP-1 to act on the vagus nerve to activate
    the gut–brain–liver nerve pathway and regulate the insulin sensitivity, glucose
    production, fatty acid oxidation. GABA, gamma-aminobutyric acid; DA, dopamine;
    NA, noradrenaline; SCFAs, short-chain fatty acids; TMAVA, N,N,N-trimethyl-5-aminovaleric
    acid; GLP-1, glucagon-like peptide-1.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Nbl1
  - da
  - Calm3
  - Cd36
  - Cpe
  - Tsc2
  - GABA-B-R1
  - Rdl
  - Gabat
  - nAChRalpha2
  - na
  - ft
  - kug
  - faf
---
